Clinical characteristics of sleep disorders in patients with Parkinson’s disease

Abstract

In order to investigate the sleep quality and influencing factors in patients with Parkinson’s disease (PD), 201 PD patients were enrolled and underwent extensive clinical evaluations. Subjective sleep evaluation was assessed using the Pittsburgh Sleep Quality Index (PSQI), and the Epworth Sleepiness Scale (ESS). It was found that poor sleep quality (77.11%) and excessive daytime sleepiness (32.34%) were commonly seen in PD patients and positively correlated with disease severity. Then 70 out of the 201 PD patients and 70 age- and sex-matched controls underwent a polysomnographic recording. The parameters were compared between PD group and control group and the influencing factors of sleep in PD patients were analyzed. The results showed that sleep efficiency (SE) was significantly decreased (P<0.01), and sleep latency (SL) and the arousal index (AI) were increased (P<0.05) in the PD group as compared with those in the control group. SE and total sleep time (TST) were positively correlated with the Hoehn and Yahr (H&Y) stage. There was significant difference in the extent of hypopnea and hypoxemia between the PD group and the control group (P<0.05). Our results indicate that PD patients have an overall poor sleep quality and a high prevalence of sleep disorder, which may be correlated with the disease severity. Respiratory function and oxygen supply are also affected to a certain degree in PD patients.

Keywords

Parkinson’s disease / sleep disorders / polysomnography / influencing factors

References

[1] RaggiA, BellaR, PennisiG, et al. . Sleep disorders in Parkinson’s disease: a narrative review of the literature. Rev Neurosci, 2013, 24(3): 279-291 PMID: 23612648

[2] PeeraullyT, YongMH, ChokrovertyS, et al. . Sleep and Parkinson’s disease: a review of case-control polysomnography studies. Mov Disord, 2012, 27(14): 1729-1737 PMID: 23115083

[3] BjørnaråKA, DietrichsE, ToftM. Clinical features associated with sleep disturbances in Parkinson’s disease. Clin Neurol Neurosurg, 2014, 124: 37-43 PMID: 25016237

[4] SuzukiK, MiyamotoM, MiyamotoT, et al. . Sleep disturbances associated with Parkinson’s disease. Parkinsons Dis, 2011, 219056(10): 17

[5] DiederichNJ, McIntyreDJ. Sleep disorders in Parkinson’s disease: many causes, few therapeutic options. J Neurol Sci, 2012, 314(1-2): 12-19 PMID: 22118862

[6] DhawanV, HealyDG, PalS, et al. . Sleep-related problems of Parkinson’s disease. Age Ageing, 2006, 35(3): 220-228 PMID: 16638765

[7] HughesAJ, DanielSE, KilfordL, et al. . Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry, 1992, 55(3): 181-184 PMID: 1564476 PMCID: 1014720

[8] TomlinsonCL, StoweR, PatelS, et al. . Systematic review of levodopa dose equivalency reporting in Parkinson’s disease. Mov Disord, 2010, 25(15): 2649-2653 PMID: 21069833

[9] BerryRB, BudhirajaR, GottliebDJ, et al. . Rules for scoring respiratory events in sleep: update of the 2007 AASM Manual for the Scoring of Sleep and Associated Events. Deliberations of the Sleep Apnea Definitions Task Force of the American Academy of Sleep Medicine. J Clin Sleep Med, 2012, 8(5): 597-619 PMID: 23066376

[10] RobertsRE, ShemaSJ, KaplanGA, et al. . Sleep complaints and depression in an aging cohort: A prospective perspective. Am J Psychiatry, 2000, 157(1): 81-88 PMID: 10618017

[11] TargaAD, RodriguesLS, NosedaAC, et al. . Unraveling a new circuitry for sleep regulation in Parkinson’s disease. Neuropharmacology, 2016, 108: 161-171 PMID: 27091486

[12] BraakH, GhebremedhinE, RubU, et al. . Stages in the development of Parkinson’s disease-related pathology. Cell Tissue Res, 2004, 318(1): 121-134 PMID: 15338272

[13] LimaMM. Sleep disturbances in Parkinson’s disease: the contribution of dopamine in REM sleep regulation. Sleep Med Rev, 2013, 17(5): 367-375 PMID: 23481545

[14] PetitD, GagnonJF, FantiniML, et al. . Sleep and quantitative EEG in neurodegenerative disorders. J Psychosom Res, 2004, 56(5): 487-496 PMID: 15172204

[15] MontiJM, JantosH. The roles of dopamine and serotonin, and of their receptors, in regulating sleep and waking. Prog Brain Res, 2008, 172: 625-646 PMID: 18772053

[16] BelaidH, AdrienJ, LaffratE, et al. . Sleep disorders in Parkinsonian macaques: effects of L-dopa treatment and pedunculopontine nucleus lesion. J Neurosci, 2014, 34(27): 9124-9133 PMID: 24990932 PMCID: 4078088

[17] ChahineLM, DaleyJ, HornS, et al. . Association between dopaminergic medications and nocturnal sleep in earlystage Parkinson’s disease. Parkinsonism Relat Disord, 2013, 19(10): 859-863 PMID: 23751512

[18] TrenkwalderC, KiesB, RudzinskaM, et al. . Rotigotine effects on early morning motor function and sleep in Parkinson’s disease: a double-blind, randomized, placebocontrolled study (RECOVER). Mov Disord, 2011, 26(1): 90-99 PMID: 21322021

[19] ComellaCL. Sleep disorders in Parkinson’s disease: an overview. Mov Disord, 2007, 22(17): 21682

[20] OndoW D, VuongK, KhanH, et al. . Daytime sleepiness and other sleep disorders in Parkinson’s disease. Neurology, 2001, 57(8): 1392-1396 PMID: 11673578

[21] YehNC, TienKJ, YangCM, et al. . Increased risk of parkinson’s disease in patients with obstructive sleep apnea: A population-based, propensity score-matched, longitudinal follow-up study. Medicine, 2016, 95(2): e2293 PMID: 26765405 PMCID: 4718231

[22] Martinez-RamirezD, de JesusS, WalzR, et al. . A polysomnographic study of parkinson’s disease sleep architecture. Parkinsons Dis, 2015, 570375(10): 4

[23] KaynakD, KiziltanG, KaynakH, et al. . Sleep and sleepiness in patients with Parkinson’s disease before and after dopaminergic treatment. Eur J Neurol, 2005, 12(3): 199-207 PMID: 15693809

[24] VinckenWG, GauthierSG, DollfussRE, et al. . Involvement of upper-airway muscles in extrapyramidal disorders. A cause of airflow limitation. N Engl J Med, 1984, 311(7): 438-442 PMID: 6749190

[25] ChenJC, TsaiTY, LiCY, et al. . Obstructive sleep apnea and risk of Parkinson’s disease: a population-based cohort study. J Sleep Res, 2015, 24(4): 432-437 PMID: 25810019